When both Tr sub-compartments were independently analyzed, it becomes evident that both Tr CD21-/lo and Tr CD21+ cells increment in COVID-19 patients and that their expansion is marked in mild/moderate cases but also remained in severe and critical courses (Figure 2C). Here, CR2 is linked to COVID-19.